申请人:Takeda Chemical Industries, Ltd.
公开号:US06420415B1
公开(公告)日:2002-07-16
Compounds represented by general formula (1) or salts thereof which have a matrix metalloprotease inhibitory activity and are useful as drugs, wherein the rings A and B represent each an optionally substituted homocycle or heterocycle, etc.; R1s are the same or different and each represents hydrogen, optionally substituted hydrocarbyl, acyl, etc.; X1 represents a bond, optionally substituted divalent aliphatic hydrocarbyl, etc.; X2 represents a bond, optionally substituted divalent aliphatic hydrocarbyl, —O—, etc.; Ys are the same or different represents hydrogen, optionally substituted hydrocarbyl, oxo, etc.; m is 0 or 1; n is an integer of 1 to 3; q1 is an integer of 1 to 2n+4; and q2 is an integer of 0 to 2n+3, provided that q1+q2 is 2n+4.
通式(1)表示的化合物或其盐具有基质金属蛋白酶抑制活性,并且可用作药物,其中环A和环B分别表示可选择取代的同环或异环等;R1s相同或不同,每个代表氢,可选择取代的烃基,酰基等;X1表示键,可选择取代的二价脂肪烃基等;X2表示键,可选择取代的二价脂肪烃基,—O—等;Ys相同或不同,代表氢,可选择取代的烃基,氧代,等;m为0或1;n为1到3的整数;q1为1到2n+4的整数;q2为0到2n+3的整数,前提是q1+q2为2n+4。